GlaxoSmithKline’s inhaled medicine Breo failed to prolong life in patients with chronic respiratory disease in a high-stakes clinical trial of…
Read More
GlaxoSmithKline’s inhaled medicine Breo failed to prolong life in patients with chronic respiratory disease in a high-stakes clinical trial of…
Read MoreThere may be 35 million older Americans with undiagnosed lung disease due to cigarette smoking, a new study suggests. They…
Read MoreResidents of low-income neighborhoods with few high school graduates may be more likely to die after lung cancer surgery than…
Read MoreA closely watched immune system-boosting drug cocktail from Britain’s AstraZeneca shows promise in advanced lung cancer, despite adverse side effects…
Read More